Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease
N/A
N/A
70 Years
N/A
70 Years
Not Enrolling
Both
Hodgkin Disease
Both
Hodgkin Disease
Trial Information
Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease
Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or
Resistant Hodgkin's Disease
Inclusion Criteria:
- adequate organ function- recurrent HD Exclusion Criteria:- CNS disease
- no prior malignancy
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Overall survival
Principal Investigator
Sally Arai
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
BMT24
NCT ID:
NCT00186251
Start Date:
March 1998
Completion Date:
July 2005
Related Keywords:
- Hodgkin Disease
- Hodgkin Disease
Name | Location |
|---|---|
| Stanford University School of Medicine | Stanford, California 94305-5317 |
